ArticleChemical science2026
Redox activation of halogen-bonding catalysts for organic synthesis.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among non-covalent interactions, halogen bonding (XB) has emerged as a sophisticated tool for molecular assembly and catalysis, distinguished from its hydrogen bonding (HB) analogues by its superior directionality and the high polarizability of the halogen atom. These characteristics offer unique opportunities for fine-tuning the strength and the geometry of this interaction to achieve targeted functionalities. Furthermore, the use of a redox-active moiety enables a controlled increase in the XB donor strength upon oxidation, effectively activating the XB donor catalyst. Herein, we report the rational design and the synthesis of ferrocene-based XB donors. Characterization of the fundamental XB interactions in the system was performed through a synergistic approach involving single-crystal X-ray diffraction and solution-phase binding studies. Density Functional Theory (DFT) analysis reveals a significant amplification of the 'σ-hole' intensity upon oxidation, a feature we exploit to drive catalytic turnover. Notably, these redox-switchable iodoferrocene derivatives serve as potent catalysts for XB-mediated Friedel-Crafts alkylation reactions, even in competitive polar solvents-a challenging environment for traditional XB catalysis. This work demonstrates the efficacy of charge modulation by redox activation in fine-tuning XB strength for organic transformation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.